Scarica l'app Stockscreener
53.88
3.16%
1.65
Dopo l'orario di chiusura:
53.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Haemonetics Corp Borsa (HAE) Ultime notizie
Is Haemonetics Corporation stock entering bullish territoryJuly 2025 Volume & Risk Managed Investment Signals - Newser
Haemonetics Corporation (NYSE:HAE) Q1 2026 Earnings Call Transcript - Insider Monkey
Is Haemonetics Corporation meeting your algorithmic filter criteriaDaily Investment Ideas with Market Insight - Newser
I’m Recommending Haemonetics Again, But With Caveats (Ratings Upgrade) (NYSE:HAE) - Seeking Alpha
Understanding Haemonetics (HAE) Reliance on International Revenue - Yahoo Finance
Haemonetics stock rating downgraded by Raymond James on vascular closure slowdown - Investing.com
Haemonetics’ (HAE) “Neutral” Rating Reiterated at JPMorgan Chase & Co. - Defense World
Mizuho Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - Defense World
Haemonetics Corporation stock outlook for YEARWealth Accumulation Outlook for Safe Investors - Newser
Haemonetics (NYSE:HAE) Receives “Buy” Rating from Needham & Company LLC - Defense World
Barrington Research Lowers Haemonetics (NYSE:HAE) Price Target to $86.00 - Defense World
Haemonetics (NYSE:HAE) Earns “Buy” Rating from Needham & Company LLC - Defense World
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $62 to $86 - 富途牛牛
Detecting price anomalies in Haemonetics Corporation with AIFree Trade Ready Stock Watch for Short Term - Newser
What makes Haemonetics Corporation stock price move sharplyAI Swing Strategy Signal Forecasting System - Newser
How to escape a deep drawdown in Haemonetics CorporationBuy Point Strategy with Profit Protection - Newser
Haemonetics Reports Q1 Fiscal 2026 Earnings - The Globe and Mail
JP Morgan Downgrades Haemonetics (HAE) - MSN
Haemonetics Corporation stock trendline breakdownFree Breakout Confirmation With Entry Tracker - Newser
Haemonetics Corp Reports Strong Organic Growth Despite Portfolio Transitions - AInvest
These Analysts Slash Their Forecasts On Haemonetics After Q1 Results - Benzinga
Haemonetics (HAE): Mizuho Lowers Price Target to $70.00 While Ma - GuruFocus
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Technical signs of recovery in Haemonetics CorporationSummary of Consistent Growth Stock Picks - Newser
Haemonetics: Fiscal Q1 Earnings Snapshot - Connecticut Post
Haemonetics stock rating cut by JPMorgan on mixed results - Investing.com
Haemonetics (NYSE:HAE) Shares Down 22.1% Following Analyst Downgrade - Defense World
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
Haemonetics Corp (HAE) Analysts Lower Price Target to $68, Maintain "Buy" Rating - AInvest
Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24% - Yahoo Finance
Analyst Needham Lowers Price Target for Haemonetics (HAE) to $68 - GuruFocus
Haemonetics stock price target lowered to $68 at Needham on competition - Investing.com Canada
Earnings call transcript: Haemonetics beats Q1 2026 earnings, stock drops - Investing.com
Haemonetics Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Haemonetics Corporation Reports Earnings Results for the First Quarter Ended June 28, 2025 - MarketScreener
Haemonetics (HAE) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Haemonetics earnings beat by $0.09, revenue topped estimates - Investing.com Canada
Haemonetics (HAE) Q1 Revenue Falls 4% - The Motley Fool
Haemonetics Corp Q1 Fiscal 2026 Earnings: Revenue Surpasses Esti - GuruFocus
Haemonetics' Q1 2025 Earnings: Strategic Resilience and Long-Term Value Amid Plasma Challenges - AInvest
Haemonetics Corporation Q1 Fiscal 2026 Results - TradingView
HAEMONETICS CORP SEC 10-Q Report - TradingView
Haemonetics Q1 FY26 Earnings Released Today: Join Live Conference Call for Full Analysis - Stock Titan
Unlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
What makes Haemonetics Corporation stock attractive to long term investorsCapital Protection Strategy With Risk Analysis - Newser
Brokerages Set Haemonetics Corporation (NYSE:HAE) Price Target at $97.30 - Defense World
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Why Haemonetics Corporation stock attracts strong analyst attentionCapital Safe Picks with Consistent Gains - Newser
Analyzing net buyer seller activity in Haemonetics CorporationDownside Control Plan With Support Analysis - Newser
Using data models to predict Haemonetics Corporation stock movementAccurate Forecast System with AI Support - Newser
Leading vs lagging indicators on Haemonetics Corporation performanceFree Chart Driven High Reward Trading Setup - Newser
What drives Haemonetics Corporation stock priceCapitalize on market trends with confidence - Jammu Links News
What analysts say about Haemonetics Corporation stockCapitalize on emerging market trends - Jammu Links News
Should you hold or exit Haemonetics Corporation nowFree High Growth Low Risk Stock Selection - Newser
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):